Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 516017, 11 pages
http://dx.doi.org/10.1155/2013/516017
Research Article

Grape-Derived Polyphenols Prevent Doxorubicin-Induced Blunted EDH-Mediated Relaxations in the Rat Mesenteric Artery: Role of ROS and Angiotensin II

1UMR CNRS 7213, Laboratoire de Biophotonique et Pharmacologie, Faculté de Pharmacie, Université de Strasbourg, 74 Route du Rhin, BP 60024, 67401 Illkirch, France
2Institut de Physiologie, Faculté de Médecine, EA 3072, 11 Rue Humann, 67000 Strasbourg, France
3Service de Physiologie et d’Explorations Fonctionnelles, Pôle de Pathologie Thoracique, NHC-1 Place de l’Hôpital, 67091 Strasbourg, France

Received 27 May 2013; Accepted 22 July 2013

Academic Editor: Yong Chool Boo

Copyright © 2013 Noureddine Idris-Khodja et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Carvalho, R. X. Santos, S. Cardoso et al., “Doxorubicin: the good, the bad and the ugly effect,” Current Medicinal Chemistry, vol. 16, no. 25, pp. 3267–3285, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. M. J. Aiken, V. Suhag, C. A. Garcia et al., “Doxorubicin-induced cardiac toxicity and cardiac rest gated blood pool imaging,” Clinical Nuclear Medicine, vol. 34, no. 11, pp. 762–767, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Šimůnek, M. Štěrba, O. Popelová, M. Adamcová, R. Hrdina, and V. Gerši, “Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron,” Pharmacological Reports, vol. 61, no. 1, pp. 154–171, 2009. View at Google Scholar · View at Scopus
  4. M. Olukman, C. Can, A. Erol, G. Öktem, O. Oral, and M. G. Çinar, “Reversal of doxorubicin-induced vascular dysfunction by resveratrol in rat thoracic aorta: is there a possible role of nitric oxide synthase inhibition?” Anadolu Kardiyoloji Dergisi, vol. 9, no. 4, pp. 260–266, 2009. View at Google Scholar · View at Scopus
  5. M. B. Wolf and J. W. Baynes, “The anti-cancer drug, doxorubicin, causes oxidant stress-induced endothelial dysfunction,” Biochimica et Biophysica Acta, vol. 1760, no. 2, pp. 267–271, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. D. D. Rees, R. M. R. Palmer, H. F. Hodson, and S. Moncada, “A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation,” British Journal of Pharmacology, vol. 96, no. 2, pp. 418–424, 1989. View at Google Scholar · View at Scopus
  7. P. M. Vanhoutte, “How we learned to say no,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 8, pp. 1156–1160, 2009. View at Google Scholar
  8. R. F. Furchgott and J. V. Zawadzki, “The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine,” Nature, vol. 288, no. 5789, pp. 373–376, 1980. View at Google Scholar · View at Scopus
  9. R. M. J. Palmer, A. G. Ferrige, and S. Moncada, “Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor,” Nature, vol. 327, no. 6122, pp. 524–526, 1987. View at Google Scholar · View at Scopus
  10. G. Chen, H. Suzuki, and A. H. Weston, “Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels,” British Journal of Pharmacology, vol. 95, no. 4, pp. 1165–1174, 1988. View at Google Scholar · View at Scopus
  11. H. Shimokawa, H. Yasutake, K. Fujii et al., “The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation,” Journal of Cardiovascular Pharmacology, vol. 28, no. 5, pp. 703–711, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Edwards, M. Félétou, and A. H. Weston, “Endothelium-derived hyperpolarising factors and associated pathways: a synopsis,” Pflügers Archiv, vol. 459, no. 6, pp. 863–879, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. C. de Wit and T. M. Griffith, “Connexins and gap junctions in the EDHF phenomenon and conducted vasomotor responses,” Pflügers Archiv, vol. 459, no. 6, pp. 897–914, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Duquaine, G. A. Hirsch, A. Chakrabarti et al., “Rapid-onset endothelial dysfunction with adriamycin: evidence for a dysfunctional nitric oxide synthase,” Vascular Medicine, vol. 8, no. 2, pp. 101–107, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Y. Chow, C. Chin, G. Dahl, and D. N. Rosenthal, “Anthracyclines cause endothelial injury in pediatric cancer patients: a pilot study,” Journal of Clinical Oncology, vol. 24, no. 6, pp. 925–928, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Toko, T. Oka, Y. Zou et al., “Angiotensin II type 1a receptor mediates doxorubicin-induced cardiomyopathy,” Hypertension Research, vol. 25, no. 4, pp. 597–603, 2002. View at Google Scholar · View at Scopus
  17. A. Hiona, A. S. Lee, J. Nagendran et al., “Pretreatment with angiotensin-converting enzyme inhibitor improves doxorubicin-induced cardiomyopathy via preservation of mitochondrial function,” Journal of Thoracic and Cardiovascular Surgery, vol. 142, no. 2, pp. 396.e3–403.e3, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Idris-Khodja, C. Auger, E. Koch, and V. B. Schini-Kerth, “Crataegus special extract WS((R))1442 prevents aging-related endothelial dysfunction,” Phytomedicine, vol. 19, no. 8-9, pp. 699–706, 2012. View at Google Scholar
  19. V. B. Schini-Kerth, N. Étienne-Selloum, T. Chataigneau, and C. Auger, “Vascular protection by natural product-derived polyphenols: in vitro and in vivo evidence,” Planta Medica, vol. 77, no. 11, pp. 1161–1167, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. V. B. Schini-Kerth, C. Auger, N. Étienne-Selloum, and T. Chataigneau, “Polyphenol-induced endothelium-dependent relaxations. Role of NO and EDHF,” Advances in Pharmacology, vol. 60, pp. 136–175, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Sarr, M. Chataigneau, S. Martins et al., “Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase,” Cardiovascular Research, vol. 71, no. 4, pp. 794–802, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Jiménez, R. López-Sepúlveda, M. Kadmiri et al., “Polyphenols restore endothelial function in DOCA-salt hypertension: role of endothelin-1 and NADPH oxidase,” Free Radical Biology and Medicine, vol. 43, no. 3, pp. 462–473, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. R. López-Sepúlveda, R. Jiménez, M. Romero et al., “Wine polyphenols improve endothelial function in large vessels of female spontaneously hypertensive rats,” Hypertension, vol. 51, no. 4, pp. 1088–1095, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Idris Khodja, T. Chataigneau, C. Auger, and V. B. Schini-Kerth, “Grape-derived polyphenols improve aging-related endothelial dysfunction in rat mesenteric artery: role of oxidative stress and the angiotensin system,” PLoS ONE, vol. 7, no. 2, Article ID e32039, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Yamaç, Ç. Elmas, C. Özoǧul, Z. Keskil, and A. Dursun, “Ultrastructural damage in vascular endothelium in rats treated with paclitaxel and doxorubicin,” Ultrastructural Pathology, vol. 30, no. 1-2, pp. 103–110, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. C.-C. Wu, S.-J. Chen, and M.-H. Yen, “Different responses to acetylcholine in the presence of nitric oxide inhibitor in rat aortae and mesenteric arteries,” Clinical and Experimental Pharmacology and Physiology, vol. 20, no. 6, pp. 405–412, 1993. View at Google Scholar · View at Scopus
  27. E. Büssemaker, R. Popp, B. Fisslthaler et al., “Aged spontaneously hypertensive rats exhibit a selective loss of EDHF-mediated relaxation in the renal artery,” Hypertension, vol. 42, no. 4, pp. 562–568, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Dal-Ros, C. Bronner, C. Schott et al., “Angiotensin II-induced hypertension is associated with a selective inhibition of endothelium-derived hyperpolarizing factor-mediated responses in the rat mesenteric artery,” Journal of Pharmacology and Experimental Therapeutics, vol. 328, no. 2, pp. 478–486, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Mather, K. A. Dora, S. L. Sandow, P. Winter, and C. J. Garland, “Rapid endothelial cell-selective loading of connexin 40 antibody blocks endothelium-derived hyperpolarizing factor dilation in rat small mesenteric arteries,” Circulation Research, vol. 97, no. 4, pp. 399–407, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. R. H. P. Hilgers and R. C. Webb, “Reduced expression of SKCa and IKCa channel proteins in rat small mesenteric arteries during angiotensin II-induced hypertension,” The American Journal of Physiology, vol. 292, no. 5, pp. H2275–H2284, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Dal-Ros, M. Oswald-Mammosser, T. Pestrikova et al., “Losartan prevents portal hypertension-induced, redox-mediated endothelial dysfunction in the mesenteric artery in rats,” Gastroenterology, vol. 138, no. 4, pp. 1574–1584, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Idris-Khodja and V. Schini-Kerth, “Thymoquinone improves aging-related endothelial dysfunction in the rat mesenteric artery,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 385, pp. 749–758, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Kansui, K. Fujii, K. Nakamura et al., “Angiotensin II receptor blockade corrects altered expression of gap junctions in vascular endothelial cells from hypertensive rats,” The American Journal of Physiology, vol. 287, no. 1, pp. H216–H224, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Krummen, A. Drouin, M.-È. Gendron, J. R. Falck, and E. Thorin, “ROS-sensitive cytochrome P450 activity maintains endothelial dilatation in ageing but is transitory in dyslipidaemic mice,” British Journal of Pharmacology, vol. 147, no. 8, pp. 897–904, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. W. Chen, L. J. Druhan, C.-A. Chen et al., “Peroxynitrite induces destruction of the tetrahydrobiopterin and heme in endothelial nitric oxide synthase: transition from reversible to irreversible enzyme inhibition,” Biochemistry, vol. 49, no. 14, pp. 3129–3137, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. T. S. Schmidt and N. J. Alp, “Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease,” Clinical Science, vol. 113, no. 1-2, pp. 47–63, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. M. A. Ibrahim, O. M. Ashour, Y. F. Ibrahim, H. I. EL-Bitar, W. Gomaa, and S. R. Abdel-Rahim, “Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity,” Pharmacological Research, vol. 60, no. 5, pp. 373–381, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. W. Arozal, K. Watanabe, P. T. Veeraveedu et al., “Effect of telmisartan in limiting the cardiotoxic effect of daunorubicin in rats,” Journal of Pharmacy and Pharmacology, vol. 62, no. 12, pp. 1776–1783, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. M.-A. Yu, L. G. Sánchez-Lozada, R. J. Johnson, and D.-H. Kang, “Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction,” Journal of Hypertension, vol. 28, no. 6, pp. 1234–1242, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. A. A. Banday and M. F. Lokhandwala, “Oxidative stress causes renal angiotensin II Type 1 receptor upregulation, Na+/H+ exchanger 3 overstimulation, and hypertension,” Hypertension, vol. 57, no. 3, pp. 452–459, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. A. A. Banday and M. F. Lokhandwala, “Oxidative stress-induced renal angiotensin AT1 receptor upregulation causes increased stimulation of sodium transporters and hypertension,” The American Journal of Physiology, vol. 295, no. 3, pp. F698–F706, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Actis-Goretta, J. I. Ottaviani, and C. G. Fraga, “Inhibition of angiotensin converting enzyme activity by flavanol-rich foods,” Journal of Agricultural and Food Chemistry, vol. 54, no. 1, pp. 229–234, 2006. View at Publisher · View at Google Scholar · View at Scopus